Biotech

All Articles

Cullinan, after $25M offer, return bispecific to Port

.Cullinan Rehab was made an impression on sufficient with Port BioMed's bispecific invulnerable reac...

A nearer take a look at Ferocious Biotech's Intense 15

.In this full week's incident of "The Leading Pipe," our company're diving in to Fierce Biotech's an...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is still flying coming from Eli Lilly's event celebrating the commendation of Alzheime...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings as...

Lykos will certainly ask FDA to reevaluate its own choice adhering to rejection of MDMA therapy for post-traumatic stress disorder

.Following a bad presenting for Lykos Therapeutics' MDMA applicant for post-traumatic stress disorde...

AN 2 fifty percents head count, quits period 3 trial after records disappoint

.AN2 Rehabs is actually rethinking its own company in response to poor midphase records, swearing to...

Merck pays $700M for bispecific, snooping autoimmune position and also opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying $700 million ahead of time to test Amgen in a blood cancer market...

Gilead spends J&ampJ $320M to go out licensing deal for seladelpar

.With Gilead Sciences on the verge of an FDA selection for its own liver condition medication selade...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may see the business setting up outdoors tents at basecamp behi...

Entero giving up personnel, abandoning workplace and also pausing R&ampD

.Mattress Liquidators has actually switched Entero Therapies white colored as a slab. The collector ...